I agree. My gut feel is that the way they are modifying the anthracycline to reduce cardiotoxicity also reduces the anti-cancer effect. It simply taking away the cytotoxic effects and thus reducing cardiotoxicity.
The ROS production aids the anti-cancer effect and thus preventing this reduces efficacy. Bisantrene has a magic wand that has (i) low cardiotoxicity (ii) protects against cardiotoxicity of other anthracyclines, and (iii) increases anti-cancer effect by way of synergy.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-11
-
- There are more pages in this discussion • 617 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.95 |
Change
0.065(3.45%) |
Mkt cap ! $327.8M |
Open | High | Low | Value | Volume |
$1.89 | $1.95 | $1.85 | $276.1K | 145.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1864 | $1.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.96 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1200 | 1.935 |
2 | 1111 | 1.930 |
1 | 565 | 1.925 |
1 | 1100 | 1.920 |
1 | 1100 | 1.915 |
Price($) | Vol. | No. |
---|---|---|
1.950 | 9208 | 3 |
1.955 | 507 | 1 |
1.960 | 1216 | 1 |
1.970 | 1000 | 1 |
1.985 | 1500 | 1 |
Last trade - 14.31pm 12/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |